Stage III non-small cell lung cancer (NSCLC) is a highly heterogeneous group of tumors with complex treatment options. Some patients can be treated surgically, while others are deemed unresectable for various reasons. For unresectable stage III NSCLC, the currently recommended treatment regimen i...

The 61st European Renal Association (ERA) Congress and European Nephrology Annual Meeting was held in Stockholm, the capital of Sweden from May 23-26, 2024. As one of the largest international nephrology conferences globally, the congress gathered the latest advances in the field of nephrology wo...

The 32nd ISMRM & ISMRT Annual Meeting & Exhibition kicked off in Singapore in May 2024. Dr. Zhao Kaixuan and Dr. Cai Zimeng from the Department of Radiology were awarded the Gold Award (Summa Cum Laude Merit Award) for their research findings at this year’s conference. It is reported that...

With the development of circulating tumor DNA (ctDNA) testing technology, the concept of Minimal Residual Disease (MRD) has emerged. Previous research by Guangdong Lung Cancer Institute has confirmed that for early-stage lung cancer patients after surgery and mid-stage lung cancer patients after ...

Approximately 8%–18% of adults in developed and developing countries worldwide suffer from chronic kidney disease (CKD). Diabetes and hypertension stand out as the two primary culprits behind CKD. Managing hyperglycemia, hypertension, and proteinuria, along with administering sodium/glucose cotra...

Papillary thyroid cancer (PTC), often abbreviated as papillary carcinoma, is the most prevalent malignant endocrine tumor, with its incidence steadily on the rise. The cellular heterogeneity within the tumor microenvironment plays a pivotal role in determining the prognosis of PTC. Spatial transc...

The latest research findings from the Lung Cancer Institute of Guangdong Provincial People’s Hospital were published online in the prestigious New England Journal of Medicine (NEJM, IF = 158.5) on the early morning of April 11, 2024. The study, named the ALINA study, is a large-scale global multi...

Recently, the latest research achievement titled “Noninvasive Artificial Intelligence System for Early Predicting Residual Cancer Burden during Neoadjuvant Chemotherapy in Breast Cancer” led by Prof. Wang Kun from the Department of Breast Cancer, in collaboration with the First People’s Hospital ...

On March 22, 2024, the 14th Annual Meeting of Cervical Spine Research Society - Asia Pacific (CSRS-AP) was held in Singapore, where top international experts in cervical spine surgery gathered to discuss the latest advancements in the field. This academic event was fully live-streamed online. Led...

The 46th San Antonio Breast Cancer Symposium, the world's largest academic conference on breast cancer, was held from December 5th to 9th, 2023, with thousands of breast cancer experts and scholars from around the world in attendance. During the conference, two research projects led by Profe...